We have a 25% TDC rate as well.  We are reviewing our policies regarding
these costs and the question came up on how to charge start up, up front,
or so called "one time" fees and whether they should be subject to indirect
cost.  What are your thoughts?

I thank you in advance,

Ron
Ronald F. Polizzi, MBA, CRA
Associate Director, Contracts
Thomas Jefferson University
Office of Research Administration
201 South 11th Street
Martin Bldg., Suite 319A
Philadelphia, PA 19107-5595
Phone:  215-503-2127
Fax:      215-503-2365

----- Original Message -----
From: "Herbert B. Chermside" <xxxxxx@VCU.EDU>
To: <xxxxxx@HRINET.ORG>
Sent: Wednesday, July 21, 2004 3:32 PM
Subject: Re: [RESADM-L] F&A Rates for Non-Clinical Corporate Sponsors

> This is a very common solution.  Drug companies look at the digits in
front
> of the % sign, and don't consider the base.  But you don't want to use the
> MTDC base, anyway, because "patient care" there is an accountant's
> definition (certain costs already loaded with indirect) rather than any
> health care provider's definition.  For that matter, your researcher
> probably doesn't understand that, either, and thinks using MTDC would
> really exclude most of the costs from the base, and so reduce his cost.
>
> Our Director of Industry Partnerships had done a recent survey, and found
> only two institutions using MTDC.  Most are getting 25 to 29% TDC.
>
> Chuck
>
>
>
> At 03:00 PM 7/21/2004, you wrote:
> >Our F&A Rates for clinical trials is a separate rate than that of
> >non-clinical research sponsored by corporate sponsors.  For example, a
> >clinical trial sponsored by Jansen is 25% TDC, but a non-clinical project
> >is the full federal rate of 46%.
> >
> >Is this the practice at your institution?  I'm just trying to get a feel
> >for how common this is.  I have a researcher that's pretty disgusted
about
> >our policy and I was curious if it's common or standard.  It's the first
> >time I've run into it.
> >
> >-Jennifer
> >
> >Jennifer Morgan, MHA
> >
> >Vice Chair for Research Administration
> >Department of Psychiatry and Behavioral Science
> >
> >Southern Section President
> >Society of Research Administrators International
> >
> >Medical University of South Carolina
> >67 President Street, Suite 504
> >Charleston, South Carolina  29425
> >
> >voice:  843-792-0191
> >fax:  843-792-0048
> >email:  xxxxxx@musc.edu
> >
> >
> >======================================================================
> >  Instructions on how to use the RESADM-L Mailing List, including
> >  subscription information and a web-searchable archive, are available
> >  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> >======================================================================
>
> Herbert B. Chermside, CRA
> Special Asst. to VP-Research
> Virginia Commonwealth University
> PO BOX 980568
> Richmond, VA  23298-0568
> Voice:  804-827-6036
> Fax     804-828-2051
> e-mail xxxxxx@vcu.edu
>
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================